Key Points
- Insider accumulation: Two directors increased holdings — Timothy P. Sullivan bought 24,154 shares at $20.69 (a 49.06% increase to 73,383 shares) and Harry Jansen Kraemer Jr. bought 36,610 shares at ~$21.41 — signaling management confidence.
- Mixed Q1 and legal risk: Q1 results showed a modest EPS beat ($0.40 vs. $0.37) but a revenue miss (~$1.35B vs. ~$1.39B) and trimmed guidance, which sparked a selloff and multiple securities‑fraud investigations and class‑action solicitations.
- Market sentiment split: Institutional ownership is very high (~98%), analysts' consensus is a Moderate Buy with an average target near $31.25, but several firms have recently cut targets (e.g., BofA to $22), reflecting divergent views.
Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) Director Timothy Sullivan bought 24,154 shares of the business's stock in a transaction on Thursday, May 7th. The stock was purchased at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the transaction, the director owned 73,383 shares of the company's stock, valued at $1,518,294.27. This trade represents a 49.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Option Care Health Stock Up 1.5%
Shares of NASDAQ OPCH opened at $20.75 on Friday. The firm has a market cap of $3.26 billion, a price-to-earnings ratio of 16.09, a PEG ratio of 1.10 and a beta of 0.68. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 52-week low of $18.01 and a 52-week high of $36.80. The business's 50 day moving average is $28.29 and its two-hundred day moving average is $30.61.
Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.03. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The firm's quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts predict that Option Care Health, Inc. will post 1.69 EPS for the current year.
Institutional Investors Weigh In On Option Care Health
A number of large investors have recently modified their holdings of OPCH. Royal Bank of Canada increased its position in shares of Option Care Health by 20.7% in the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company's stock valued at $8,078,000 after purchasing an additional 39,661 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company's stock valued at $1,450,000 after purchasing an additional 25,777 shares during the last quarter. Empowered Funds LLC purchased a new stake in shares of Option Care Health in the 1st quarter valued at approximately $208,000. Invesco Ltd. increased its position in shares of Option Care Health by 2.7% in the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company's stock valued at $9,561,000 after purchasing an additional 7,678 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company's stock valued at $46,000 after purchasing an additional 1,183 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.
Trending Headlines about Option Care Health
Here are the key news stories impacting Option Care Health this week:
- Positive Sentiment: Two directors made sizeable purchases, increasing insider ownership and signaling management confidence — Timothy P. Sullivan bought 24,154 shares at ~$20.69 (May 7). Sullivan SEC Filing
- Positive Sentiment: Director Harry Jansen Kraemer Jr. purchased 36,610 shares at ~$21.41 (May 4), further highlighting insider accumulation. Kraemer SEC Filing
- Neutral Sentiment: Morgan Stanley reaffirmed an "Overweight" rating (institutional support remains), and other analysts show a split view — Consensus remains a "Moderate Buy" with an average target around $32, but recent price targets vary. Analyst Coverage
- Neutral Sentiment: Management will speak at the Bank of America Health Care Conference (May 12), which could be a catalyst for clarification on execution and outlook. Conference Notice
- Negative Sentiment: Multiple securities‑fraud investigations and shareholder class‑action solicitations were launched after the April 30 Q1 report and a subsequent revenue/guidance revision — this raises potential legal, financial and reputational risk that could pressure the stock. Representative notices: Levi & Korsinsky, Holzer & Holzer, Block & Leviton and others. Holzer Alert Block & Leviton
- Negative Sentiment: Q1 fundamentals were mixed: EPS beat modestly ($0.40 vs. $0.37) but revenue missed (~$1.35B vs. ~$1.39B) and management trimmed full‑year revenue/earnings outlooks, prompting a sharp prior selloff and heightened execution concerns. Earnings & Guidance
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and set a $22.00 target price on the stock. in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their target price on shares of Option Care Health from $40.00 to $33.00 and set an "overweight" rating on the stock in a report on Monday. TD Cowen reduced their target price on shares of Option Care Health from $37.00 to $23.00 and set a "hold" rating on the stock in a report on Friday, May 1st. Jefferies Financial Group reiterated a "buy" rating and set a $37.00 target price on shares of Option Care Health in a report on Tuesday, January 13th. Finally, Morgan Stanley set a $28.00 target price on shares of Option Care Health in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $31.25.
View Our Latest Analysis on OPCH
Option Care Health Company Profile
(
Get Free Report)
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
